News Commentary | January 04, 2021
GenoPalate intends to use the funding to double its customer capacity to at least 3,000 people daily. Sales growth for personalized nutrition startups appears to be flourishing, with multiple CEOs citing record sales in 2020 to Lux. GenoPalate could very well be on a similar trajectory. Moving into ... Not part of subscription
News Commentary | May 18, 2021
When Teladoc acquired Livongo, it didn't just get a diabetes platform – it acquired an ecosystem of services around mental health, postnatal, and cardiovascular care. Teladoc will certainly be building out its capabilities in the coming months using the scaffolding that Livongo created, and it is ... To read more, click here.
News Commentary | June 02, 2021
The news comes from the company's public filing of a $1.2 billion SPAC deal, which it intends to use to raise funds for its full‑stack wearable sensor platform. Its sensor suite includes the capability to measure biomarkers like hydration, muscle lactate, and blood glucose. Measuring blood glucose ... Not part of subscription
by Danielle Bradnan
Google's role in healthcare analytics has been documented in digital therapeutics and through hospital systems like Ascension. It is now looking to telehealth as an additional pillar in its healthcare strategy by partnering with Amwell. Google is likely seeing Amwell as a strong player as one of the three biggest telehealth companies in the U.S., but it should be wary. In order to survive against competitors, Amwell will need a consumer-facing remote monitoring solution to compete with rival Teladoc, which just partnered with Livongo. With its recent cash influx from both Google and COVID-19 hype, clients can view Amwell as an opportune target for remote monitoring sales.
For the original news article, click here .